MIRM Other | Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2024-03-15: Form 10-K; Item Smaller reporting company; As filed Yes.
2023-11-02: Form 10-Q; Item Smaller reporting company; As filed Yes.
2023-11-02: Form 10-Q; Item Emerging growth company; As filed Yes.
2023-08-07: Form 10-Q; Item Smaller reporting company; As filed Yes.

Filed	Form	Item	As filed
2024-03-15	10-K	Smaller reporting company	Yes
2023-11-02	10-Q	Smaller reporting company	Yes
2023-11-02	10-Q	Emerging growth company	Yes
2023-08-07	10-Q	Smaller reporting company	Yes
2023-08-07	10-Q	Emerging growth company	Yes
2023-05-04	10-Q	Smaller reporting company	Yes
2023-05-04	10-Q	Emerging growth company	Yes
2023-03-08	10-K	Smaller reporting company	Yes
2023-03-08	10-K	Emerging growth company	Yes
2022-11-09	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · The Nasdaq Global Market
2022-11-09	10-Q	Smaller reporting company	Yes
2022-11-09	10-Q	Emerging growth company	Yes
2022-08-04	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · The Nasdaq Global Market
2022-08-04	10-Q	Smaller reporting company	Yes
2022-08-04	10-Q	Emerging growth company	Yes
2022-05-05	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · The Nasdaq Global Market
2022-05-05	10-Q	Smaller reporting company	Yes
2022-05-05	10-Q	Emerging growth company	Yes
2022-03-09	10-K	Smaller reporting company	Yes
2022-03-09	10-K	Emerging growth company	Yes
2022-03-09	10-K	Well-known seasoned issuer	No
2021-11-15	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · The Nasdaq Global Market
2021-11-15	10-Q	Smaller reporting company	Yes
2021-11-15	10-Q	Emerging growth company	Yes
2021-08-05	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · The Nasdaq Global Market
2021-08-05	10-Q	Smaller reporting company	Yes
2021-08-05	10-Q	Emerging growth company	Yes
2021-05-06	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · NASDAQ
2021-05-06	10-Q	Smaller reporting company	Yes
2021-05-06	10-Q	Emerging growth company	Yes
2021-03-09	10-K	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · NASDAQ
2021-03-09	10-K	Smaller reporting company	Yes
2021-03-09	10-K	Emerging growth company	Yes
2021-03-09	10-K	Well-known seasoned issuer	No
2020-11-12	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · NASDAQ
2020-11-12	10-Q	Smaller reporting company	Yes
2020-11-12	10-Q	Emerging growth company	Yes
2020-08-06	10-Q	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · MIRM · NASDAQ
2020-08-06	10-Q	Smaller reporting company	Yes
2020-08-06	10-Q	Emerging growth company	Yes
2020-05-07	10-Q	Stock registered under Section 12(b)	Common stock · MIRM · NASDAQ
2020-05-07	10-Q	Smaller reporting company	Yes
2020-05-07	10-Q	Emerging growth company	Yes
2020-03-12	10-K	Stock registered under Section 12(b)	Common stock · MIRM · NASDAQ
2020-03-12	10-K	Smaller reporting company	Yes
2020-03-12	10-K	Emerging growth company	Yes
2020-03-12	10-K	Well-known seasoned issuer	No
2019-11-06	10-Q	Stock registered under Section 12(b)	Common stock · MIRM · NASDAQ
2019-11-06	10-Q	Smaller reporting company	Yes
2019-11-06	10-Q	Emerging growth company	Yes
2019-08-28	10-Q	Stock registered under Section 12(b)	Common stock · MIRM · NASDAQ
2019-08-28	10-Q	Smaller reporting company	Yes
2019-08-28	10-Q	Emerging growth company	Yes
2019-08-28	10-Q	Current in its reporting	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Liquidia Corp (LQDA)	United States	$6.347B	51.23
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Veradermics, Inc (MANE)	United States	$4.839B